A Novel Score to Predict One-Year Mortality after Transcatheter Aortic Valve Replacement, Naples Prognostic Score

Author:

Çetin Zehra Güven1ORCID,Balun Ahmet2ORCID,Çiçekçioğlu Hülya1ORCID,Demirtaş Bekir3ORCID,Yiğitbaşı Murat Mehmet4,Özbek Kerem1,Çetin Mustafa1

Affiliation:

1. Cardiology Department, Ankara Bilkent City Hospital, 06800 Ankara, Turkey

2. Cardiology Department, Bandırma Onyedi Eylul University, 10200 Balıkesir, Turkey

3. Cardiology Department, Ankara Etlik City Hospital, 06170 Ankara, Turkey

4. Sarıkamıs State Hospital, 36500 Kars, Turkey

Abstract

Background and Objectives: Aortic stenosis (AS) is a widespread valvular disease in developed countries, primarily among the elderly. Transcatheter aortic valve replacement (TAVR) has become a viable alternative to aortic valve surgery for patients with severe AS who are deemed a high surgical risk or for whom the AS is found to be inoperable. Predicting outcomes after TAVR is essential. The Naples Prognostic Score (NPS) is a new scoring method that evaluates nutritional status and inflammation. Our study is aims to examine the relationship between the NPS and outcomes for patients receiving TAVR. Material and Methods: We conducted a retrospective study of 370 patients who underwent TAVR across three tertiary medical centres from March 2019 to March 2023. The patients were divided into two groups based on their NPS, namely, low (0, 1, and 2) and high (3 and 4). Our study is primarily aimed to determine the one-year mortality rate. Results: Within one year, the mortality rate for the entire group was 8.6%. Nonetheless, the low-NPS group had a rate of 5.0%, whereas the high-NPS group had a rate of 13%. The difference between the two groups was statistically significant, with a p-value of 0.06. Conclusions: Our results show that NPS is an independent predictor of one-year mortality in patients undergoing TAVR.

Publisher

MDPI AG

Subject

General Medicine

Reference30 articles.

1. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey;Iung;Circulation,2019

2. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Otto;Circulation,2021

3. 2021 ESC/EACTS Guidelines for the management of valvular heart disease;Vahanian;Eur. Heart J.,2022

4. The Society of Thoracic Surgeons National Cardiac Surgery Database: Current Risk Assessment;Edwards;Ann. Thorac. Surg.,1997

5. European system for cardiac operative risk evaluation (EuroSCORE);Nashef;Eur. J. Cardio-Thorac. Surg.,1999

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3